Loading stock…

The Procter & Gamble Company (PG) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

PGThe Procter & Gamble

Revenue FY26$87.0B

GROWTH RATING↗

VERY WEAK14 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+2%3

Revenue, next 3Y, CAGR+3%2

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+7%6

EPS growth, FY28E+5%5

EPS growth, FY29E+5%5

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue grew 2%/yr over the last 3 years and is set to keep growing around 3%/yr.

Earnings are set to grow in step with sales (EPS about 5%/yr vs revenue 3%/yr).

WEAKNESSES

Growth is the weak spot here, trailing 86% of companies worldwide.

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE53 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+2%8

3-month return+0%6

YTD return+5%6

MID & LONG-TERM▾SCORE

% of 52-week high90%8

1-year return+1%5

3-year return+11%3

5-year return+19%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 1% over the past year, but 10% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+2%).

WATCH

Returns sit at the market level over three months (+0%) and so far this year (+5%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+11% over three years and +19% over five), behind 60% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Procter & Gamble. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

PGThe Procter & Gamble

Revenue FY26$87.0B

GROWTH RATING↗

VERY WEAK14 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+2%4

Revenue, next 1Y+2%3

Revenue, next 3Y, CAGR+3%2

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+7%6

EPS growth, FY28E+5%5

EPS growth, FY29E+5%5

GROWTH ASSESSMENT

STRENGTHS

None flagged.

WATCH

Revenue grew 2%/yr over the last 3 years and is set to keep growing around 3%/yr.

Earnings are set to grow in step with sales (EPS about 5%/yr vs revenue 3%/yr).

WEAKNESSES

Growth is the weak spot here, trailing 86% of companies worldwide.

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE53 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+2%8

3-month return+0%6

YTD return+5%6

MID & LONG-TERM▾SCORE

% of 52-week high90%8

1-year return+1%5

3-year return+11%3

5-year return+19%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 1% over the past year, but 10% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+2%).

WATCH

Returns sit at the market level over three months (+0%) and so far this year (+5%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+11% over three years and +19% over five), behind 60% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Procter & Gamble. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

The Procter & Gamble Company

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Procter & Gamble. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Procter & Gamble. Get the full investment case.

Premium